TERRY HAGAN: Open Payments
NPI 1689663718 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 38 payments from 12 companies in 2025. Trend: 2023 $592 · 2024 $3,279 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $137 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
| ABBVIE INC. | 6 | $120 |
| Corium, LLC | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $51 |
| Noven Therapeutics, LLC | 2 | $37 |
| Neos Therapeutics, LP | 2 | $30 |
| Bausch Health US, LLC | 1 | $23 |
Products named: HETLIOZ, VRAYLAR, Azstarys, REXULTI, ARISTADA, CAPLYTA, LYBALVI, Xelstrym.
Industry payments across KY — which companies pay providers there.
